Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03562741 · ClinicalTrials.gov registry record · NA
Outcomes and Data Collection for Fecal Microbiota Transplantation for the Treatment of Recurrent Clostridium Difficile
A NA study of Clostridium Difficile Infection and Clostridium Difficile Infection Recurrence, sponsored by Krunal Patel.
- Recruiting
- Registry status
- NA
- Development phase
- 500
- Enrollment target
- 1
- Study location
NCT03562741 is a NA study of Clostridium Difficile Infection and Clostridium Difficile Infection Recurrence that is actively recruiting participants, run by Krunal Patel. The registered enrollment target is 500 participants, below the 12,027-participant average among 13 other Clostridium Difficile Infection trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03562741, a NA study of Clostridium Difficile Infection and Clostridium Difficile Infection Recurrence, is actively recruiting participants, sponsored by Krunal Patel.
- RECRUITING
- Registry status
- NA
- Development phase
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to see if stool transplant performed by colonoscopy is effective at treating recurrent Clostridium difficile (C. diff) infection of the colon. During the procedure a stool sample is taken from a healthy donor (usually family member or close friend) and transplanted directly into the colon of the patient with C. diff infection. The goal of this experimental procedure (called fecal microbiota transplantation) is to replenish the good bacteria in the colon that can help prevent C. diff infection from coming back after treatment.
Conditions Studied
Interventions
- PROCEDURE Fecal Microbiota Transplantation
Study Locations (1)
Massachusetts
- UMass Memorial Medical Center - Worcester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2014-01-16 |
| Est. Completion | 2029-01-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03562741
The ClinicalTrials.gov registry entry for NCT03562741 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,027-participant average among 13 other Clostridium Difficile Infection trials with a reported enrollment target (96% lower). The listed sponsor is Krunal Patel, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Clostridium Difficile Infection appearing as the primary indexed condition, and to 1 intervention - of which Fecal Microbiota Transplantation is the first listed.
NCT03562741 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03562741 about?
NCT03562741 is a clinical study titled "Outcomes and Data Collection for Fecal Microbiota Transplantation for the Treatment of Recurrent Clostridium Difficile". The purpose of this study is to see if stool transplant performed by colonoscopy is effective at treating recurrent Clostridium difficile (C. diff) infection of the colon. During the procedure a stool sample is taken from a healthy donor (usually family member or close friend) and transplanted direc...
What is the current status of trial NCT03562741?
This trial is currently recruiting. It is a NA study. The enrollment target is 500 participants. The study started on 2014-01-16. Estimated completion is 2029-01-16.
What conditions does trial NCT03562741 study?
This clinical trial studies the following conditions: Clostridium Difficile Infection, Clostridium Difficile Infection Recurrence.
What interventions are being tested in trial NCT03562741?
The interventions under investigation include: Fecal Microbiota Transplantation (PROCEDURE).
Who is sponsoring clinical trial NCT03562741?
This trial is sponsored by Krunal Patel, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03562741 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Clostridium Difficile Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Fecal Microbiota Transplantation for C Diff Infection
RECRUITING · NA
-
Validation of the GenePOC CDiff Assay for the Detection of the Toxin B Gene From Toxigenic Clostridium Difficile Strains
COMPLETED · NA
-
Alanyl-glutamine Supplementation for C. Difficile Treatment (ACT)
RECRUITING · Phase 2
-
Fecal Microbiota Transplant National Registry
RECRUITING
-
Enteral Vancomycin as Primary Prophylaxis Against Clostridioides Difficile Infection in Critically Ill Patients
RECRUITING · Phase 2
-
Protocol for Admission Toxigenic C. Difficile Surveillance
COMPLETED
Explore more on PlainTrial
Clostridium Difficile Infection
All registered trials for this condition
Clostridium Difficile Infection Recurrence
All registered trials for this condition
Massachusetts
All trials with a study site in Massachusetts
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.